Press

In the face of climate challenges, agriculture stands at a crossroads. In France, it accounts for 18% of greenhouse gas emissions, yet it can also significantly contribute to biodiversity preservation.
How can agriculture be transformed to combine decarbonization with the economic viability of farms?
To answer this question, Groupama supported a study on the decarbonization of agriculture. This work was conducted by The Shift Project, a non-profit organization that brings together scientists and experts from various fields to inform and influence public debate on climate and energy issues. The study, based on large-scale consultation with 8,000 farmers, proposes a central "conciliation" scenario.
As France's leading agricultural insurer and an Agricultural Professional Organization, Groupama has backed this scientific and economic approach.
Discover the conclusions of this research.

Groupama's cooperative DNA and long-standing commitment have always expressed themselves across the French territories - as illustrated by the testimonies in our latest annual report, On the Fields. Day after day, the Group brings together proximity, solidarity, and responsibility toward its policyholders and clients, thanks especially to its strong local presence. In early 2025, with support from In France - a company specialized in corporate data analysis - each regional mutual produced a territorial anchoring report. These documents offer a comprehensive view of our regional reach and the positive impact that our operations have locally. Spending on suppliers, claims, jobs... Discover how Groupama actively contributes to the economic vitality and sustainable development of French regions.

Groupama has just released its 2024 Climate Report. As a testament to our commitments and ongoing efforts, this voluntarily published report transparently outlines our sustainability approach, risks, and the actions and pledges we've put in place for a more sustainable Group.

The Groupama Foundation is celebrating its 25th anniversary this year. On June 19, the Foundation honored innovations and projects that support people living with rare diseases in their daily lives. Meet the award recipients!

In 2024, Groupama launched a certification program to label its actions and commitments to sustainability, through the Afnor "Committed to CSR" label.
This label, based on the ISO 26000 standard, was awarded to 14 entities of the Group in France: 1 entity at the "exemplary" level and 13 entities at the "confirmed" level - clear recognition of Groupama's positive impact in sustainable development.

Volt'Terre is a program designed to create innovative solutions for clients and teams by fostering collaboration between local start-ups and Groupama business units. This approach contributes to the Group's ambition to become a champion in customer support.

Discover Spareka and Continuity, two innovative companies dedicated to enhancing the satisfaction of our clients and members.

Groupama announced the issue on 19 May 2025 of Euro-denominated Fixed Rate subordinated notes due 2035 placed with institutional investors for a principal amount of EUR 500 million. The new notes priced at MS+190, resulting in an annual coupon of 4.375%. The purpose of this transaction was to take advantage of current supportive market conditions to optimize the group's capital structure.

Groupama aims to build a mutual insurance group that excels in customer support, and this ambition is evident across the Group internationally. Our Bulgarian, Greek, Hungarian, Italian, Romanian, Chinese, and Tunisian entities have been recognized with various awards-here's the story behind them.

The Groupama Foundation is celebrating its 25th anniversary! To mark the occasion, it has launched the Employee Award, allowing employees to sponsor projects from rare disease associations. Employees have shown great enthusiasm, sponsoring a total of 36 projects! The Foundation's Operational Committee reviewed these projects and selected 4 finalists. Now, Group employees are invited to vote for the project they believe has the greatest impact on the daily lives of sick children.
The winning project will receive €10,000!
Below, discover the finalist projects.